{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:16:32Z","timestamp":1767856592365,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12028-023-01827-w","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:41:46Z","timestamp":1694637706000},"page":"886-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Early Celecoxib use in Patients with Traumatic Brain Injury"],"prefix":"10.1007","volume":"40","author":[{"given":"Debarati","family":"Bhanja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Hallan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Staub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Christopher","family":"Zacko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"issue":"9","key":"1827_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrneurol.2017.116","volume":"13","author":"DW Simon","year":"2017","unstructured":"Simon DW, McGeachy MJ, Bay\u0131r H, Clark RSB, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol. 2017;13(9):572. https:\/\/doi.org\/10.1038\/nrneurol.2017.116.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"1827_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10571-016-0400-1","volume":"37","author":"ML Pearn","year":"2017","unstructured":"Pearn ML, Niesman IR, Egawa J, et al. Pathophysiology associated with traumatic brain injury: current treatments and potential novel therapeutics. Cell Mol Neurobiol. 2017;37(4):571\u201385. https:\/\/doi.org\/10.1007\/s10571-016-0400-1.","journal-title":"Cell Mol Neurobiol"},{"key":"1827_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cyto.2018.01.012","volume":"110","author":"T Rodney","year":"2018","unstructured":"Rodney T, Osier N, Gill J. Pro- and anti-inflammatory biomarkers and traumatic brain injury outcomes: a review. Cytokine. 2018;110:248\u201356. https:\/\/doi.org\/10.1016\/j.cyto.2018.01.012.","journal-title":"Cytokine"},{"issue":"1","key":"1827_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12974-016-0786-1","volume":"14","author":"KM Webster","year":"2017","unstructured":"Webster KM, Sun M, Crack P, O\u2019Brien TJ, Shultz SR, Semple BD. Inflammation in epileptogenesis after traumatic brain injury. J Neuroinflammation. 2017;14(1):10. https:\/\/doi.org\/10.1186\/s12974-016-0786-1.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1827_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1203\/PDR.0b013e3180db2902","volume":"62","author":"RW Hickey","year":"2007","unstructured":"Hickey RW, Adelson PD, Johnnides MJ, et al. Cyclooxygenase-2 activity following traumatic brain injury in the developing rat. Pediatr Res. 2007;62(3):271\u20136. https:\/\/doi.org\/10.1203\/PDR.0b013e3180db2902.","journal-title":"Pediatr Res"},{"issue":"Pt 3","key":"1827_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.expneurol.2015.05.024","volume":"275","author":"PJ Bergold","year":"2016","unstructured":"Bergold PJ. Treatment of traumatic brain injury with anti-inflammatory drugs. Exp Neurol. 2016;275(Pt 3):367\u201380. https:\/\/doi.org\/10.1016\/j.expneurol.2015.05.024.","journal-title":"Exp Neurol"},{"issue":"6301","key":"1827_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1126\/science.aaf6260","volume":"353","author":"MV Russo","year":"2016","unstructured":"Russo MV, McGavern DB. Inflammatory neuroprotection following traumatic brain injury. Science. 2016;353(6301):783\u20135. https:\/\/doi.org\/10.1126\/science.aaf6260.","journal-title":"Science"},{"key":"1827_CR8","first-page":"1","volume":"97","author":"S Levant","year":"2016","unstructured":"Levant S, Chari K, DeFrances C. National hospital care survey demonstration projects: traumatic brain injury. Natl Health Stat Report. 2016;97:1\u201316.","journal-title":"Natl Health Stat Report"},{"issue":"1","key":"1827_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.injury.2016.10.042","volume":"48","author":"PA Tardif","year":"2017","unstructured":"Tardif PA, Moore L, Boutin A, et al. Hospital length of stay following admission for traumatic brain injury in a Canadian integrated trauma system: a retrospective multicenter cohort study. Injury. 2017;48(1):94\u2013100. https:\/\/doi.org\/10.1016\/j.injury.2016.10.042.","journal-title":"Injury"},{"issue":"3","key":"1827_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/ANA.0000000000000434","volume":"30","author":"R Chaudhry","year":"2018","unstructured":"Chaudhry R, Kukreja N, Tse A, et al. Trends and outcomes of early versus late percutaneous endoscopic gastrostomy placement in patients with traumatic brain injury: nationwide population-based study. J Neurosurg Anesthesiol. 2018;30(3):251\u20137. https:\/\/doi.org\/10.1097\/ANA.0000000000000434.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"5","key":"1827_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00134-020-05935-5","volume":"46","author":"C Robba","year":"2020","unstructured":"Robba C, Galimberti S, Graziano F, et al. Tracheostomy practice and timing in traumatic brain-injured patients: a CENTER-TBI study. Intensive Care Med. 2020;46(5):983\u201394. https:\/\/doi.org\/10.1007\/s00134-020-05935-5.","journal-title":"Intensive Care Med"},{"key":"1827_CR12","doi-asserted-by":"publisher","unstructured":"Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI. Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien) 2008;150(2):165\u201375; discussion 175. https:\/\/doi.org\/10.1007\/s00701-007-1475-8.","DOI":"10.1007\/s00701-007-1475-8"},{"issue":"9475","key":"1827_CR13","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/S0140-6736(05)66552-X","volume":"365","author":"P Edwards","year":"2005","unstructured":"Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005;365(9475):1957\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(05)66552-X.","journal-title":"Lancet"},{"issue":"3","key":"1827_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/neuros\/nyaa278","volume":"87","author":"GWJ Hawryluk","year":"2020","unstructured":"Hawryluk GWJ, Rubiano AM, Totten AM, et al. Guidelines for the management of severe traumatic brain injury: 2020 update of the decompressive craniectomy recommendations. Neurosurgery. 2020;87(3):427\u201334. https:\/\/doi.org\/10.1093\/neuros\/nyaa278.","journal-title":"Neurosurgery"},{"issue":"5","key":"1827_CR15","first-page":"1102","volume":"15","author":"Z Keshavarzi","year":"2012","unstructured":"Keshavarzi Z, Khaksari M, Razmi Z, Soltani Hekmat A, Naderi V, Rostami S. The effects of cyclooxygenase inhibitors on the brain inflammatory response following traumatic brain injury in rats. Iran J Basic Med Sci. 2012;15(5):1102\u20135.","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"1827_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/neu.2000.17.69","volume":"17","author":"PK Dash","year":"2000","unstructured":"Dash PK, Mach SA, Moore AN. Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury. J Neurotrauma. 2000;17(1):69\u201381. https:\/\/doi.org\/10.1089\/neu.2000.17.69.","journal-title":"J Neurotrauma"},{"issue":"1","key":"1827_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/traumacare1010003","volume":"1","author":"M Hiskens","year":"2021","unstructured":"Hiskens M, Vella R, Schneiders A, Fenning A. Celecoxib in a preclinical model of repetitive mild traumatic brain injury: hippocampal learning deficits persist with inflammatory and excitotoxic neuroprotection. Trauma Care. 2021;1(1):23\u201337. https:\/\/doi.org\/10.3390\/traumacare1010003.","journal-title":"Trauma Care"},{"issue":"6","key":"1827_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1179\/016164109X12464612122731","volume":"32","author":"T Hakan","year":"2010","unstructured":"Hakan T, Toklu HZ, Biber N, et al. Effect of COX-2 inhibitor meloxicam against traumatic brain injury-induced biochemical, histopathological changes and blood-brain barrier permeability. Neurol Res. 2010;32(6):629\u201335. https:\/\/doi.org\/10.1179\/016164109X12464612122731.","journal-title":"Neurol Res"},{"key":"1827_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.brainres.2012.10.049","volume":"1491","author":"H Girgis","year":"2013","unstructured":"Girgis H, Palmier B, Croci N, Soustrat M, Plotkine M, Marchand-Leroux C. Effects of selective and non-selective cyclooxygenase inhibition against neurological deficit and brain oedema following closed head injury in mice. Brain Res. 2013;1491:78\u201387. https:\/\/doi.org\/10.1016\/j.brainres.2012.10.049.","journal-title":"Brain Res"},{"key":"1827_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3389\/fneur.2019.00811","volume":"10","author":"K Dehlaghi Jadid","year":"2019","unstructured":"Dehlaghi Jadid K, Davidsson J, Lidin E, et al. COX-2 inhibition by diclofenac is associated with decreased apoptosis and lesion area after experimental focal penetrating traumatic brain injury in rats. Front Neurol. 2019;10:811. https:\/\/doi.org\/10.3389\/fneur.2019.00811.","journal-title":"Front Neurol"},{"issue":"2","key":"1827_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/neu.2010.1673","volume":"29","author":"O Thau-Zuchman","year":"2012","unstructured":"Thau-Zuchman O, Shohami E, Alexandrovich AG, Trembovler V, Leker RR. The anti-inflammatory drug carprofen improves long-term outcome and induces gliogenesis after traumatic brain injury. J Neurotrauma. 2012;29(2):375\u201384. https:\/\/doi.org\/10.1089\/neu.2010.1673.","journal-title":"J Neurotrauma"},{"issue":"3","key":"1827_CR22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1227\/01.neu.0000154060.14900.8f","volume":"56","author":"JJ Gopez","year":"2005","unstructured":"Gopez JJ, Yue H, Vasudevan R, et al. Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery. 2005;56(3):590\u2013604. https:\/\/doi.org\/10.1227\/01.neu.0000154060.14900.8f.","journal-title":"Neurosurgery"},{"issue":"11","key":"1827_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1046\/j.1440-1681.2001.03549.x","volume":"28","author":"I Cernak","year":"2001","unstructured":"Cernak I, O\u2019Connor C, Vink R. Activation of cyclo-oxygenase-2 contributes to motor and cognitive dysfunction following diffuse traumatic brain injury in rats. Clin Exp Pharmacol Physiol. 2001;28(11):922\u20135. https:\/\/doi.org\/10.1046\/j.1440-1681.2001.03549.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"1827_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00221-002-1245-z","volume":"147","author":"I Cernak","year":"2002","unstructured":"Cernak I, O\u2019Connor C, Vink R. Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats. Exp Brain Res. 2002;147(2):193\u20139. https:\/\/doi.org\/10.1007\/s00221-002-1245-z.","journal-title":"Exp Brain Res"},{"issue":"3","key":"1827_CR25","first-page":"239","volume":"13","author":"HS Karabekir","year":"2008","unstructured":"Karabekir HS, Balci C, Aktepe F, Tokyol C, Dilek H. Which is more effective in reducing secondary brain damage resulting from cyclooxygenase expression following traumatic brain injury: calcium channel blockers or cox inhibitors? Neurosciences (Riyadh). 2008;13(3):239\u201343.","journal-title":"Neurosciences (Riyadh)"},{"issue":"5","key":"1827_CR26","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3171\/jns.2002.96.5.0892","volume":"96","author":"JM Schwab","year":"2002","unstructured":"Schwab JM, Beschorner R, Meyermann R, G\u00f6zalan F, Schluesener HJ. Persistent accumulation of cyclooxygenase-1-expressing microglial cells and macrophages and transient upregulation by endothelium in human brain injury. J Neurosurg. 2002;96(5):892\u20139. https:\/\/doi.org\/10.3171\/jns.2002.96.5.0892.","journal-title":"J Neurosurg"},{"issue":"12","key":"1827_CR27","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1590\/1414-431X20143601","volume":"47","author":"JL Shang","year":"2014","unstructured":"Shang JL, Cheng Q, Yang WF, Zhang M, Cui Y, Wang YF. Possible roles of COX-1 in learning and memory impairment induced by traumatic brain injury in mice. Braz J Med Biol Res. 2014;47(12):1050\u20136.","journal-title":"Braz J Med Biol Res"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-023-01827-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-023-01827-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-023-01827-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T22:05:16Z","timestamp":1717452316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-023-01827-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1827"],"URL":"https:\/\/doi.org\/10.1007\/s12028-023-01827-w","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"assertion":[{"value":"18 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors confirm adherence to ethical guidelines and indicate ethical approvals, including institutional review board policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}